Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.91M | 2.22M | 1.91M | 1.26M | 2.14M | 1.53M |
Gross Profit | 1.91M | -1.21M | -1.45M | -2.53M | -2.96M | 1.63K |
EBITDA | -25.07M | -21.82M | -22.88M | -21.82M | -28.67M | -281.25M |
Net Income | -24.24M | -23.08M | -24.24M | -23.10M | -30.24M | -281.54M |
Balance Sheet | ||||||
Total Assets | 35.25M | 21.09M | 35.25M | 56.92M | 78.24M | 42.56M |
Cash, Cash Equivalents and Short-Term Investments | 32.54M | 16.33M | 32.54M | 53.73M | 73.26M | 39.75M |
Total Debt | 1.28M | 3.68M | 1.28M | 1.94M | 2.39M | 1.46M |
Total Liabilities | 6.04M | 8.18M | 6.04M | 6.02M | 7.08M | 5.81M |
Stockholders Equity | 29.21M | 12.91M | 29.21M | 50.90M | 71.16M | 36.76M |
Cash Flow | ||||||
Free Cash Flow | -20.47M | -20.42M | -20.47M | -19.70M | -25.02M | -13.60M |
Operating Cash Flow | -20.39M | -20.39M | -20.39M | -19.59M | -24.55M | -13.19M |
Investing Cash Flow | 7.38M | 16.84M | 7.38M | 347.00K | -25.37M | -588.64K |
Financing Cash Flow | -847.00K | 4.41M | -847.00K | -403.00K | 58.85M | 34.26M |
Axilion has announced an update to the terms of its convertible securities following a rights offering. This move signifies Axilion’s strategic financial adjustments which may affect its standing on the Tel Aviv Stock Exchange and could have implications for its stakeholders as the company continues to evolve in the financial market.
Axilion has announced an upcoming investors’ conference to be held via an online Zoom webinar. The conference is a significant event for stakeholders as it underscores Axilion’s commitment to transparency and engagement with investors, with the company’s securities being traded on the Tel Aviv Stock Exchange.